Alkem Laboratories Ltd Dividend 2024 Record Date, Share Price, History

News: Alkem Laboratories Ltd, a prominent pharmaceutical company, has recently declared its dividend for the year 2024. In this article, we’ll delve into the details of Alkem’s dividend, including the record date, share price impact, and a brief history.

Dividend Details

For the fiscal year ending March 2023, Alkem Laboratories announced an equity dividend of 2500%, amounting to Rs 50 per share. This substantial dividend reflects the company’s commitment to rewarding its shareholders.

Record Date

The record date for the dividend is a crucial milestone. On this date, the company identifies shareholders eligible to receive the dividend. For Alkem Laboratories’ 2024 dividend, the record date is yet to be officially announced. Investors should keep an eye out for updates from the company.

Share Price Impact

Dividends often influence a company’s share price. When a dividend is declared, it can attract more investors, leading to increased demand for the stock. However, the exact impact depends on various factors, including market sentiment, financial performance, and overall economic conditions.

As of now, Alkem Laboratories’ share price stands at Rs 5327.90. Investors should monitor any fluctuations in the share price around the record date to make informed decisions.

Historical Context

Alkem Laboratories has a track record of consistent performance and shareholder-friendly policies. Investors can explore the company’s historical dividend payouts and stock performance to gain insights into its financial stability and growth prospects.

Subscribe to Sarkari Result to stay informed. Get the latest celebrity news and detailed movie reviews in real-time. Keep up with the constantly changing world of entertainment with Sarkari Exam.

About Alkem Laboratories Ltd :

Alkem Laboratories Limited, headquartered in Mumbai, India, is a renowned multinational pharmaceutical company. Let’s explore more about Alkem:

Company Overview

Alkem Laboratories has a remarkable legacy spanning nearly five decades. It holds a prominent position as one of the world’s leading global pharmaceutical formulation development, manufacturing, and marketing companies originating from India. Here are some key points about Alkem:

• Core Focus: Alkem specializes in the production and sale of pharmaceutical generics, formulations, and nutraceuticals in India and across the globe.
• Employee Strength: With over 21,000 employees, Alkem operates across 40 countries and boasts 19 facilities along with 5 research and development (R&D) centers.
• Technological Advancements: Alkem prioritizes cutting-edge technology to drive innovations in healthcare. Its 20 facilities, spread across India and the USA, contribute to breaking research barriers.
• Founders: Alkem Laboratories was founded by Samprada Singh and Basudeo Narain Singh on August 8, 1973.

Alkem Laboratories’ dividend announcement for 2024 is a positive sign for shareholders. As the company continues to thrive in the pharmaceutical sector, investors can expect further updates regarding the record date and dividend distribution.

Disclaimer: Please note that all content and tools on this website are provided for your convenience and are offered “as is” without warranties. The information provided, including any tool-generated output, is for informational purposes only and should not be considered investment advice or guarantees. Exercise caution, seek professional advice, and make independent judgments before acting on any information found on this site.